Pham Quang X 13D/13G Filings for Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Pham Quang X 13D and 13G filings for Cadrenal Therapeutics, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-12
9:42 pm
Purchase
2023-12-31 13G Cadrenal Therapeutics, Inc. Common Stock
CVKD
Pham Quang X 421,667
48.570%
421,667increase
(New Position)
Filing